FDA.reportPublic FDA data

POLYETHYLENE GLYCOL 400

Substance profile for UNII B697894SGQ, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Substance Identity#

UNII
B697894SGQ
Preferred term
POLYETHYLENE GLYCOL 400
Registry number
25322-68-3
EC number
225-856-4
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
Polymer substance not supported

Chemical And Database Identifiers#

RxCUI
8514
PubChem
0
NCIt
C84080
INN ID
0

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
RxNorm8514mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=8514
NCI ThesaurusC84080ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C84080
FDA Substance Registration SystemB697894SGQprecision.fda.gov/uniisearch/srs/unii/B697894SGQ
European Community number225-856-4commonchemistry.cas.org/results?q=225-856-4

DailyMed Socrata Ingredients#

Type, DailyMed label, SPL version table
TypeDailyMed labelSPL version
INACTIVE INGREDIENTCYCLOBENZAPRINE HYDROCHLORIDE4
INACTIVE INGREDIENTCYCLOBENZAPRINE HYDROCHLORIDE5
INACTIVE INGREDIENTCARVEDILOL - carvedilol tablet Sun Pharmaceutical Industries, Inc. These highlights do not include all the information needed to use Carvedilol Tablets safely and effectively. See full prescribing information for Carvedilol Tablets, USP. Carvedilol Tablets, USP Initial U.S. Approval: 199513
INACTIVE INGREDIENTThese highlights do not include all the information needed to use topiramate tablets, USP safely and effectively. See full prescribing information for topiramate tablets, USPTopiramate Tablets, USP for oral use Initial U.S. Approval: 19965
INACTIVE INGREDIENTDrug Facts5
INACTIVE INGREDIENTTOPIRAMATE6
INACTIVE INGREDIENTThese highlights do not include all the information needed to use levofloxacin tablets safely and effectively. See full prescribing information for levofloxacin tablets. LEVOFLOXACIN Tablet, Film Coated for Oral use Initial U.S. Approval: 19969
INACTIVE INGREDIENTESCITALOPRAM OXALATE6
INACTIVE INGREDIENTThese highlights do not include all the information needed to use duloxetine delayed-release capsules, USP safely and effectively. See full prescribing information for duloxetine delayed-release capsules, USP. DULOXETINE delayed-release capsules USP, for oral use. Initial U.S. Approval: 20047
INACTIVE INGREDIENTThese highlights do not include all the information needed to use LEVOCETIRIZINE dihydrochloride tablets safely and effectively. See full prescribing information for LEVOCETIRIZINE dihydrochloride tablets. LEVOCETIRIZINE dihydrochloride tablets for oral use Initial U.S. Approval: 19957
INACTIVE INGREDIENTNeuro Max Pain and Muscle Relief Gel6
INACTIVE INGREDIENTThese highlights do not include all the information needed to use zolpidem tartrate tablets safely and effectively. See full prescribing information for zolpidem tartrate tablets ZOLPIDEM Tartrate Tablets USP, for oral use CIV Initial U.S. Approval: 19928
INACTIVE INGREDIENTRx only4
INACTIVE INGREDIENTCitalopram Tablets USP, film-coated Rx Only4
INACTIVE INGREDIENTMetformin Hydrochloride Tablets USP Rx Only4
INACTIVE INGREDIENTCitalopram Tablets, USP Rx Only4
INACTIVE INGREDIENTSertraline Tablets, USP 25 mg, 50 mg and 100 mg Rx Only27
INACTIVE INGREDIENTPleasure Balm9
INACTIVE INGREDIENTThese highlights do not include all the information needed to use carvedilol safely and effectively. See full prescribing information for Carvedilol Tablets, USP. Carvedilol Tablets, USP film coated for oral use Initial U.S. Approval: 199511
ACTIVE MOIETY9bcdd044-e3b4-4f8c-89d5-b0db33767f9d4
ACTIVE INGREDIENT9bcdd044-e3b4-4f8c-89d5-b0db33767f9d4
INACTIVE INGREDIENTf174edbd-3ac0-4e27-a116-3b74804721bb4
INACTIVE INGREDIENTVENLAFAXINE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES USP 7384 7385 7386 Rx only7
ACTIVE INGREDIENT8d6f13bb-0fb6-4e66-8a8b-72612d3aacf25
ACTIVE MOIETY8d6f13bb-0fb6-4e66-8a8b-72612d3aacf25
INACTIVE INGREDIENTDRUG FACTS1001
INACTIVE INGREDIENTThese highlights do not include all the information needed to use carvedilol safely and effectively. See full prescribing information for carvedilol tablets, USP. Carvedilol Tablets, USP Initial U.S. Approval: 19951001
INACTIVE INGREDIENTThese highlights do not include all the information needed to use eszopiclone safely and effectively. See full prescribing information for eszopiclone tablets. Eszopiclone Tablets for oral use CIV Initial U.S. Approval: 20041001
INACTIVE INGREDIENTCetirizine Hydrochloride Tablets6
INACTIVE INGREDIENTThese highlights do not include all the information needed to use amlodipine besylate and benazepril hydrochloride capsules safely and effectively. See full prescribing information for amlodipine besylate and benazepril hydrochloride capsules. Amlodipine Besylate and Benazepril Hydrochloride Capsules Initial U.S. Approval: 19951001
INACTIVE INGREDIENTThese highlights do not include all the information needed to use levofloxacin tablets safely and effectively. See full prescribing information for levofloxacin tablets. LEVOFLOXACIN Tablet, Film Coated for Oral use Initial U.S. Approval: 19967
INACTIVE INGREDIENTCitalopram Tablets, USP Rx Only5
INACTIVE INGREDIENTThese highlights do not include all the information needed to use OXYCODONE HCl EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for OXYCODONE HCl EXTENDED-RELEASE TABLETS. OXYCODONE HCl EXTENDED-RELEASE TABLETS, for oral use, CII Initial U.S. Approval: 195010
INACTIVE INGREDIENTDrug Facts4
INACTIVE INGREDIENTf398f8a9-92f3-47cb-81c2-6078806a464d4
INACTIVE INGREDIENTCitalopram Tablets, USP5
INACTIVE INGREDIENTDrug Facts9
INACTIVE INGREDIENTDrug Facts7
INACTIVE INGREDIENTThese highlights do not include all the information needed to use SEROQUEL XR safely and effectively. See full prescribing information for SEROQUEL XR. SEROQUEL XR (quetiapine fumarate) extended-release tablets, for oral use Initial U.S. Approval: 1997 ®10
INACTIVE INGREDIENTd6cee57f-5252-4d5f-b7a4-3ed344ffe2134
INACTIVE INGREDIENTInsect Bite Relief Swabs4
INACTIVE INGREDIENTThese highlights do not include all the information needed to use fluvoxamine maleate tablets USP safely and effectively. See full prescribing information for fluvoxamine maleate tablets USP. Fluvoxamine maleate tablets USP, for oral use Initial U.S. Approval: 19944
INACTIVE INGREDIENTBisacodyl Enteric Coated Tablet7
INACTIVE INGREDIENTOndansetron Hydrochloride Tablets5
INACTIVE INGREDIENTVENLAFAXINE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES 7384 7385 7386 Rx only6
INACTIVE INGREDIENTThese highlights do not include all the information needed to use carvedilol safely and effectively. See full prescribing information for carvedilol tablets, USP. Carvedilol Tablets, USP Initial U.S. Approval: 19951000
INACTIVE INGREDIENTThese highlights do not include all the information needed to use levofloxacin tablets safely and effectively. See full prescribing information for levofloxacin tablets. LEVOFLOXACIN tablets for oral use Initial U.S. Approval: 1996 To reduce the development of drug-resistant bacteria and maintain the effectiveness of levofloxacin and other antibacterial drugs, levofloxacin should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria.1000
INACTIVE INGREDIENTThese highlights do not include all the information needed to use AVANDAMET safely and effectively. See full prescribing information for AVANDAMET. AVANDAMET (rosiglitazone maleate and metformin hydrochloride) Tablets Initial U.S. Approval: 20026
INACTIVE INGREDIENTDrug Facts4
INACTIVE INGREDIENTVerapamil Hydrochloride Tablets USP Revised: November 2008 Rx Only 1743884
INACTIVE INGREDIENTd54a97d5-3664-4ca5-bffd-8366c7255b738
INACTIVE INGREDIENTThese highlights do not include all the information needed to use levetiracetam safely and effectively. See full prescribing information for levetiracetam. Levetiracetam Tablets, USP Initial U.S. Approval: 19997
INACTIVE INGREDIENTCiprofloxacin Extended-Release Tablets5
INACTIVE INGREDIENTSentralopram AM-109
INACTIVE INGREDIENTThese highlights do not include all the information needed to use donepezil hydrochloride tablets safely and effectively. See full prescribing information for donepezil hydrochloride tablets. Donepezil Hydrochloride Tablets,5 mg and 10 mg Initial U.S. Approval: 19965
INACTIVE INGREDIENTDrug Facts5
INACTIVE INGREDIENTdrug facts11
INACTIVE INGREDIENTBC10445
INACTIVE INGREDIENTLIFElabs, a Division of Atico International USA, INC.5
INACTIVE INGREDIENTMetformin Hydrochloride Tablets USP4
INACTIVE INGREDIENTeb0cd037-1e48-42b1-92ef-4d4ede585bb86
ACTIVE INGREDIENTDrug Facts5
INACTIVE INGREDIENTThese highlights do not include all the information needed to use RISPERIDONE safely and effectively. See full prescribing information for RISPERIDONE. RISPERIDONE tablet for oral use Risperidone Tablets, USP Initial U.S. Approval 19935
INACTIVE INGREDIENTTEMPRA (ACETAMINOPHEN) TABLET [BRISTOL-MYERS SQUIBB DE MEXICO, S. DE R.L. DE C.V.]20155
INACTIVE INGREDIENTLEVAQUIN (LEVOFLOXACIN) TABLET, FILM COATED [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]4005
INACTIVE INGREDIENTCIPROFLOXACIN (CIPROFLOXACIN HYDROCHLORIDE) TABLET, FILM COATED [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]3996
INACTIVE INGREDIENTAMITRIPTYLINE HYDROCHLORIDE TABLET, FILM COATED [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3976
INACTIVE INGREDIENTCITALOPRAM TABLET [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3973
INACTIVE INGREDIENTDICLOFENAC SODIUM TABLET, DELAYED RELEASE [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]3965
INACTIVE INGREDIENTHYDROXYZINE HYDROCHLORIDE TABLET, FILM COATED [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3961
INACTIVE INGREDIENTBUPROPION HYDROCHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3959
INACTIVE INGREDIENTSERTRALINE HYDROCHLORIDE TABLET [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3958
INACTIVE INGREDIENTMETOPROLOL TARTRATE TABLET [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3954
INACTIVE INGREDIENTTRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN TABLET [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3940
INACTIVE INGREDIENTZOLPIDEM TARTRATE TABLET, FILM COATED [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3937
INACTIVE INGREDIENTONDANSETRON HYDROCHLORIDE TABLET, FILM COATED [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]3925
INACTIVE INGREDIENTKETOROLAC TROMETHAMINE TABLET, FILM COATED [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3904
INACTIVE INGREDIENTNABUMETONE TABLET, FILM COATED [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3893
INACTIVE INGREDIENTFLURBIPROFEN TABLET, FILM COATED [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3878
INACTIVE INGREDIENTTRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN TABLET [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3872
INACTIVE INGREDIENTTRIAMTERENE AND HYDROCHLOROTHIAZIDE CAPSULE [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3834
INACTIVE INGREDIENTPHENAZOPYRIDINE HYDROCHLORIDE (PHENAZOPYRIDINE) TABLET [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]3828
INACTIVE INGREDIENTALL DAY RELIEF (NAPROXEN SODIUM) TABLET [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3824
INACTIVE INGREDIENTFLUOXETINE HYDROCHLORIDE TABLET, FILM COATED [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]3816
INACTIVE INGREDIENTFEXOFENADINE HYDROCHLORIDE TABLET [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3814
INACTIVE INGREDIENTCELLCEPT (MYCOPHENOLATE MOFETIL) TABLET, FILM COATED [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3807
INACTIVE INGREDIENTNAMENDA (MEMANTINE HYDROCHLORIDE) TABLET [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3742
INACTIVE INGREDIENTONDANSETRON HYDROCHLORIDE TABLET, FILM COATED [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]3730
INACTIVE INGREDIENTPREMARIN (CONJUGATED ESTROGENS) TABLET, FILM COATED [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3692
INACTIVE INGREDIENTPREMARIN (CONJUGATED ESTROGENS) TABLET, FILM COATED [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3690
INACTIVE INGREDIENTULTRAM (TRAMADOL HYDROCHLORIDE) TABLET, COATED [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]3685
INACTIVE INGREDIENTCIPROFLOXACIN (CIPROFLOXACIN HYDROCHLORIDE) TABLET [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]3602
INACTIVE INGREDIENTOXYCONTIN (OXYCODONE HYDROCHLORIDE) TABLET, FILM COATED, EXTENDED RELEASE [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]3474
INACTIVE INGREDIENTOXYCONTIN (OXYCODONE HYDROCHLORIDE) TABLET [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]3445
INACTIVE INGREDIENTHYDROCODONE BITARTRATE AND IBUPROFEN TABLET, FILM COATED [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]3325
INACTIVE INGREDIENTMETFORMIN HYDROCHLORIDE (METFORMIN HYDROCHLORIDE) TABLET, FILM COATED [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]3282
INACTIVE INGREDIENTCYCLOBENZAPRINE HYDROCHLORIDE (CYCLOBENZAPRINE HYDROCHLORIDE) TABLET, FILM COATED [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCT LLC]3256
INACTIVE INGREDIENTIBU (IBUPROFEN) TABLET [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]3242
INACTIVE INGREDIENTZOLPIDEM TARTRATE TABLET, FILM COATED [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]3182
INACTIVE INGREDIENTONDANSETRON HYDROCHLORIDE TABLET, FILM COATED [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3071
INACTIVE INGREDIENTMIRTAZAPINE TABLET, FILM COATED [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]2140
INACTIVE INGREDIENTOXYCONTIN (OXYCODONE HYDROCHLORIDE) TABLET, FILM COATED, EXTENDED RELEASE [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]2101
INACTIVE INGREDIENTZIPSOR (DICLOFENAC POTASSIUM) CAPSULE, LIQUID FILLED [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS]2043
INACTIVE INGREDIENTTOPIRAMATE TABLET, FILM COATED [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]2008
INACTIVE INGREDIENTKALETRA (LOPINAVIR AND RITONAVIR) TABLET, FILM COATED KALETRA (LOPINAVIR AND RITONAVIR) SOLUTION [ABBVIE INC.]1567
INACTIVE INGREDIENTNORVIR (RITONAVIR) TABLET, FILM COATED NORVIR (RITONAVIR) SOLUTION [ABBVIE INC.]1509
INACTIVE INGREDIENTKALETRA (LOPINAVIR AND RITONAVIR) TABLET, FILM COATED [PD-RX PHARMACEUTICALS, INC.]1405
INACTIVE INGREDIENTCIPROFLOXACIN TABLET, FILM COATED [BRYANT RANCH PREPACK]1004
INACTIVE INGREDIENTASPIRIN TABLET, DELAYED RELEASE [BRYANT RANCH PREPACK]1002
INACTIVE INGREDIENTESZOPICLONE TABLET, FILM COATED [BRYANT RANCH PREPACK]1001
INACTIVE INGREDIENTLAMIVUDINE AND ZIDOVUDINE TABLET, FILM COATED [BRYANT RANCH PREPACK]1001
INACTIVE INGREDIENTNALTREXONE HYDROCHLORIDE TABLET, FILM COATED [BRYANT RANCH PREPACK]1001
INACTIVE INGREDIENTVENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [BRYANT RANCH PREPACK]1001
INACTIVE INGREDIENTATOVAQUONE AND PROGUANIL HCL (ATOVAQUONE AND PROGUANIL HYDROCHLORIDE) TABLET, FILM COATED [BRYANT RANCH PREPACK]1000
INACTIVE INGREDIENTBICALUTAMIDE TABLET [BRYANT RANCH PREPACK]1000
INACTIVE INGREDIENTBRILINTA (TICAGRELOR) TABLET [BRYANT RANCH PREPACK]1000
INACTIVE INGREDIENTBUPROPION HYDROCHLORIDE TABLET, FILM COATED [BRYANT RANCH PREPACK]1000
INACTIVE INGREDIENTCHLOROQUINE PHOSPHATE (CHLOROQUINE PHOSPHATE) TABLET, FILM COATED [BRYANT RANCH PREPACK]1000
INACTIVE INGREDIENTCHLOROQUINE PHOSPHATE TABLET, FILM COATED [BRYANT RANCH PREPACK]1000
INACTIVE INGREDIENTDOCUSATE SODIUM AND SENNA (DOCUSATE SODIUM AND SENNA ) TABLET, FILM COATED [BRYANT RANCH PREPACK]1000

Inactive Ingredient Database#

Browse recovered IID releases and source provenance.

Current IID rows for UNII B697894SGQ page 1 of 1 · 36 matching rows.

Ingredient, UNII, CAS table
IngredientUNIICASDosage formRoutePotencyMaximum daily exposure
POLYETHYLENE GLYCOL 400B697894SGQ25322683INJECTIONINTRAMUSCULAR406 mg
POLYETHYLENE GLYCOL 400B697894SGQ25322683INJECTION, SOLUTIONINTRAMUSCULAR20.3 %w/v
POLYETHYLENE GLYCOL 400B697894SGQ25322683INJECTIONINTRAVENOUS28216 mg
POLYETHYLENE GLYCOL 400B697894SGQ25322683INJECTION, SOLUTIONINTRAVENOUS24186 mg
POLYETHYLENE GLYCOL 400B697894SGQ25322683SPRAY, METEREDNASAL320 mg
POLYETHYLENE GLYCOL 400B697894SGQ25322683SOLUTIONOPHTHALMIC46 mg
POLYETHYLENE GLYCOL 400B697894SGQ25322683SOLUTION/ DROPSOPHTHALMIC1 %w/v
POLYETHYLENE GLYCOL 400B697894SGQ25322683CAPSULEORAL13440 mg
POLYETHYLENE GLYCOL 400B697894SGQ25322683CAPSULE, DELAYED RELEASEORAL26 mg
POLYETHYLENE GLYCOL 400B697894SGQ25322683CAPSULE, EXTENDED RELEASEORAL17 mg
POLYETHYLENE GLYCOL 400B697894SGQ25322683CAPSULE, LIQUID FILLEDORAL1122 mg
POLYETHYLENE GLYCOL 400B697894SGQ25322683CONCENTRATEORAL3000 mg
POLYETHYLENE GLYCOL 400B697894SGQ25322683FILM, SOLUBLEORAL29 mg
POLYETHYLENE GLYCOL 400B697894SGQ25322683SOLUTIONORAL70200 mg
POLYETHYLENE GLYCOL 400B697894SGQ25322683SOLUTION, CONCENTRATEORAL2813 mg
POLYETHYLENE GLYCOL 400B697894SGQ25322683SUSPENSIONORAL400 mg
POLYETHYLENE GLYCOL 400B697894SGQ25322683SYRUPORAL740 mg
POLYETHYLENE GLYCOL 400B697894SGQ25322683TABLETORAL193 mg
POLYETHYLENE GLYCOL 400B697894SGQ25322683TABLET, DELAYED RELEASEORAL35 mg
POLYETHYLENE GLYCOL 400B697894SGQ25322683TABLET, EXTENDED RELEASEORAL60 mg
POLYETHYLENE GLYCOL 400B697894SGQ25322683TABLET, FILM COATEDORAL20 mg
POLYETHYLENE GLYCOL 400B697894SGQ25322683TABLET, FILM COATED, EXTENDED RELEASEORAL2 mg
POLYETHYLENE GLYCOL 400B697894SGQ25322683TABLET, ORALLY DISINTEGRATINGORAL2 mg
POLYETHYLENE GLYCOL 400B697894SGQ25322683SUPPOSITORYRECTAL0.25 mg/mg
POLYETHYLENE GLYCOL 400B697894SGQ25322683AEROSOL, POWDERTOPICALNA
POLYETHYLENE GLYCOL 400B697894SGQ25322683CREAMTOPICAL10 %w/w
POLYETHYLENE GLYCOL 400B697894SGQ25322683EMULSIONTOPICAL1.2 %w/w
POLYETHYLENE GLYCOL 400B697894SGQ25322683GELTOPICAL6300 mg
POLYETHYLENE GLYCOL 400B697894SGQ25322683LIQUIDTOPICAL1 %w/w
POLYETHYLENE GLYCOL 400B697894SGQ25322683LOTIONTOPICAL5 %w/w
POLYETHYLENE GLYCOL 400B697894SGQ25322683OINTMENTTOPICAL1950 mg
POLYETHYLENE GLYCOL 400B697894SGQ25322683SOLUTIONTOPICAL11100 mg
POLYETHYLENE GLYCOL 400B697894SGQ25322683SPONGETOPICALNA
POLYETHYLENE GLYCOL 400B697894SGQ25322683SWABTOPICAL5250 mg
POLYETHYLENE GLYCOL 400B697894SGQ25322683GELVAGINAL1250 mg
POLYETHYLENE GLYCOL 400B697894SGQ25322683SUPPOSITORYVAGINAL30 mg